Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06195839 · ClinicalTrials.gov registry record · NA

Building Engagement Using Financial Incentives Trial - Hypertension

A NA study, sponsored by Tulane University.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT06195839: Completed NA study, sponsored by Tulane University.

NCT06195839 is a NA study that has completed, run by Tulane University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06195839, a NA study, has completed, sponsored by Tulane University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQHCs). The main questions it aims to answer are: * Do patients randomized to receive financial incentives on a weekly basis during the study (immediate) have better adherence to blood pressure self-monitoring compared to patients randomized to receive financial incentives at the end of the study (delayed)? * Do patients randomized to immediate financial incentives have better blood pressure control compared to patients randomized to delayed incentives? Participants will: * attend a baseline visit to measure blood pressure, respond to a baseline survey, and receive remote patient monitoring devices and instructions to take home with them (home blood pressure monitor, wrist-worn sensor to track sleep activity, and associated apps) * receive a random allocation to one of two groups: control condition (receive cash incentives at the end of the study for measuring blood pressure as instructed) or intervention condition (receive weekly cash incentives throughout the study for measuring blood pressure as instructed) * use remote patient monitoring devices during a two month study period, receive weekly reports on adherence to blood pressure monitoring, and receive weekly financial incentives (intervention condition only) * attend one follow-up visit at 2 months to measure their blood pressure, complete a follow-up survey, return the remote patient monitoring devices, and receive financial incentives for blood pressure monitoring (control condition only) Researchers will compare the immediate and delayed incentive groups to see if there are differences in blood pressure monitoring adherence rates and blood pressure control.

Primary Outcome

Weekly adherence to blood pressure monitoring will be defined as the number of days that the participant used the home blood pressure monitor at least once, captured in the blood pressure monitoring app usage data.

Interventions

  • BEHAVIORAL Remote Patient Monitoring
  • BEHAVIORAL Self-monitoring of hypertension-related factors
  • BEHAVIORAL Immediate financial incentives
  • BEHAVIORAL Delayed financial incentives

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-05-22
Est. Completion 2025-09-11
Phase NA
Tulane University

73 total trials

What the finished NCT06195839 record still lists

NCT06195839 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 4 interventions - of which Remote Patient Monitoring is the first listed.

NCT06195839 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06195839 about?

NCT06195839 is a clinical study titled "Building Engagement Using Financial Incentives Trial - Hypertension". The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQ...

What is the current status of trial NCT06195839?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-05-22. Estimated completion is 2025-09-11.

What interventions are being tested in trial NCT06195839?

The interventions under investigation include: Remote Patient Monitoring (BEHAVIORAL), Self-monitoring of hypertension-related factors (BEHAVIORAL), Immediate financial incentives (BEHAVIORAL), Delayed financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT06195839?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06195839's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06195839, the US trial registry maintained by the National Library of Medicine. NCT06195839 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.